Product Introduction:
Vogli GM Tablet combines Voglibose (alpha-glucosidase inhibitor), Metformin (biguanide), and Glimepiride (sulfonylurea) to improve glycemic control in Type 2 diabetes mellitus by reducing blood glucose levels and controlling postprandial spikes.
Uses:
-
Management of Type 2 diabetes mellitus
-
Control of post-meal blood sugar increases
-
Improvement of overall glycemic levels
Benefits:
-
Lowers fasting and postprandial glucose levels
-
Enhances insulin secretion and sensitivity
-
Reduces carbohydrate absorption from the intestine
Composition:
-
Voglibose 0.2 mg
-
Metformin Hydrochloride 500 mg
-
Glimepiride 2 mg
Side Effects:
Possible side effects include:
-
Hypoglycemia (low blood sugar)
-
Gastrointestinal discomfort (nausea, diarrhea)
-
Dizziness or headache
-
Allergic reactions (rare)
Consult your healthcare provider if side effects are severe or persistent.
Safety Advice:
-
Pregnancy & Breastfeeding: Use only under medical supervision.
-
Alcohol: Avoid alcohol consumption.
-
Driving: Avoid driving if dizziness or hypoglycemia occurs.
-
Storage: Store in a cool, dry place away from direct sunlight.
-
Dosage: Take as prescribed by your doctor.
